Microbicide Trials Network
16
0
0
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
4 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Bone Mineral Density Substudy - An Ancillary Study to MTN-003
Role: collaborator
Rectal Microbicide Acceptability, Tolerability and Adherence
Role: lead
Study of Dapivirine Vaginal Ring (VR) in Adolescents
Role: collaborator
Microbicide/PrEP Acceptability Among Mothers and Male Partners in Africa
Role: lead
Couple User Preferences in Dual Purpose Prevention Products
Role: lead
Assessment of ASPIRE and HOPE Adherence
Role: lead
Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women
Role: collaborator
Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Role: collaborator
Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
Role: collaborator
An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003)
Role: lead
Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Role: lead
HIV-1 Resistance at Screening for HIV Prevention Studies
Role: lead
EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Role: lead
Safety and Adherence of a Non-medicated Intravaginal Ring (IVR)
Role: collaborator
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
Role: collaborator
Safety and Acceptability of SPL7013 Gel (VivaGel™) in Sexually Active Women
Role: collaborator
All 16 trials loaded